3409 results for «2023»
3409 results
What does lifetime management mean for the valve patient?
10 Jan 2024 – From PCR London Valves 2023
Bettina Kirk, Alexandra Baer and John Webb discuss the question of lifetime management for valve disease patients, and begin by outlining the main difficulties involved, offering both an interventional cardiologist's and a nurse's perspective.
Then, they are considering how this lifetime management could be improved in the...
Recent clinical evidence for mitral TEER the CLASP IID trial
06 Dec 2023 – From PCR London Valves 2023
What is the CLASP IID registry and what are the key learnings from 1-year data? Philipp Lurz and Jörg Hausleiter describe the methodology of the programme which compares Pascal vs Mitraclip in patients with degenerative mitral regurgitation. Discover the key findings which are relevant to your practice.
This...
DurAVR early safety and feasibility of a new class of biomimetic transcatheter aortic valve
05 Dec 2023 – From PCR London Valves 2023
DurAVR is a new TAVR valve which can mimic the shape of an original aortic valve. In this roundtable, Michael Reardon, Christopher Meduri, and Azeem Latib discuss this new technology, its key features, and the unmet medical needs it aims to answer. Find out more about...
TAVI pathway optimisation in Europe, insights and evidence
29 Nov 2023 – From PCR London Valves 2023
In this roundtable, Francesco Saia, Derk Frank and Douglas Muir discuss the need for TAVI pathway optimisation and Edwards' clinical project called Benchmark program, which comprises the best practices based on the evidence regarding pre- peri-and post-procedural TAVI phases.
This interview was filmed at PCR London Valves...
How can the latest long-term TAVI evidence impact our daily decision-making?
Join Antoinette Neylon, Didier Tchétché and Ole De Backer as they discuss the key issues in terms of lifetime management of TAVI patients, the learnings from the 10-year TAVI NOTION, the 4-year Evolut Low Risk, and the impact on initial device choice.
This interview was filmed at...
Treating a wide range of patient anatomies with the PASCAL implants
06 Dec 2023 – From PCR London Valves 2023
Sam Dawkins, Niklas Schofer and Mirjam Wild share the latest experience on Pascal implants for mitral and tricuspid TEER. Together they discuss the rationale for using the same device for mitral and tricuspid, how the skills and knowledge on MR can be used for TR,...
The revolution coming to tricuspid valve treatment with the EVOQUE replacement system
06 Dec 2023 – From PCR London Valves 2023
Marianna Adamo and Philipp Lurz summarize the results of the TRISCEND II randomized trial which addresses the question of transcatheter tricuspid replacement (using the EVOQUE system) vs OMT. Find out more about the key findings at 6 months and the relevance for your practice
This interview was...
EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...
Results from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast reduction) Trial
16 May 2023 – From EuroPCR 2023
Javier Escaned joins Ajay Kirtane to discuss the DCR4C Trial he conducted, and more specifically to present the main results.
The framework of the study was the contrast reduction during PCI, which is closely related to what is now known as ultra-low contrast PCI, and which mainly concerns particularly...
The CorFlow MOCA I Trial: learnings from the first-in-human direct measurement of microvascular obstruction in STEMI
16 May 2023 – From EuroPCR 2023
To help you better understand the MOCA I Late-Breaking clinical Trial and its findings, follow this exchange between Rob Schwartz, Marco Valgimigli, and Azeem Latib.
What is this study about? What technology are we talking about exactly? Why is it important for clinical practice? How can we...
New developments in intravascular lithotripsy after 5 years of clinical practice
17 May 2023 – From EuroPCR 2023
Angela McInerney and James Spratt look back at 5 years of intravascular lithotripsy and how it has evolved from its beginnings to the present day.
Calcium has always been a very complex issue especially in older patients, but the tools to treat it were somewhat limited....
The remaining big questions in transcatheter tricuspid valve intervention
18 Dec 2023 – From PCR London Valves 2023
Rebecca Hahn, Anita Asgar and Scott Lim discuss where management and treatment of tricuspid valve diseases stand today.
Even if the subject has finally found its place, a number of questions remain unanswered and deserve to be addressed: Who are the patients that should be treated with...
What is the role of imaging and physiology in complex bifurcation PCI?
Gabor Toth and Mariano Pellicano share some thoughts and perspectives on the role of coronary physiology and imaging in complex bifurcation PCI.
While physiology is an invaluable aid in understanding the functional relevance of a stenosis or circumflex bifurcation, imaging is a fantastic tool for understanding anatomy, for monitoring...
ABCs on how to decrease radiation exposure
17 May 2023 – From EuroPCR 2023
Madji Saada, James Nolan and Ariel Roguin describe radiation in the cathlab before setting out the basic rules to follow to be protected against it.
The cathlab is potentially the most irradiating environment in which a healthcare professional can work and, over a long period, it can...
Managing antiplatelet/antithrombotic use for high-bleeding risk patients
17 May 2023 – From EuroPCR 2023
Marie-Claude Morice and Davide Capodanno meet to discuss antiplatelet treatment in HBR patients.
In the past, a short DAPT with regular regimen was recommended for these patients, but it is now much more elaborated, as a standardized nomenclature has been established, proposing 3 types of escalation for...
Ultra-thin strut stenting to manage challenges in STEMI
17 May 2023 – From EuroPCR 2023
Dilip Kumar and Praveen Chandra discuss the issues and nuances in the treatment of ST-segment elevation myocardial infarction, with a particular focus on the use of ultra-thin strut stents in the treatment of primary angioplasty, or primary STEMI treatment.
After reviewing the situation in India, they take...
Is the invasive treatment of pulmonary embolism ready for prime time?
17 May 2023 – From EuroPCR 2023
In many parts of the world, pulmonary embolism is not a field traditionally reserved for cardiologists, but Catalin Toma and Andrew Sharp explain why they should be involved in its treatment.
As it is an RV failure problem that evolves from subclinical to frank shock, given that cardiologists...
Current strategies for surgical and transcatheter tricuspid valve repair and replacement
05 Dec 2023 – From PCR London Valves 2023
Watch this roundtable discussion between Julien Dreyfus, Lenard Conradi and Philipp Lurz to learn more about the latest developments in tricuspid regurgitation treatment. They begin by stressing the importance of disease status, which must be assessed quickly and accurately, and of the balance to be reached...
Who are eligible patients for transcatheter mitral valve replacement?
05 Dec 2023 – From PCR London Valves 2023
While surgical mitral valve replacement or repair and transcatheter edge-to-edge repair (TEER) are two well established techniques, Alison Duncan and Lenard Conradi explore the place that transcatheter mitral valve replacement (TMVR) now holds.
They describe how and why patients who, for clinical reasons, are not suitable candidates...
Contemporary surgical & transcatheter treatment options for severe aortic regurgitation patients
05 Dec 2023 – From PCR London Valves 2023
Two cardiac surgeons, Hendrik Treede and Michael Reardon, and an echo specialist, Joao Cavalcante, have been invited to share their views on aortic regurgitation management.
So far, surgery remains the gold standard, and they explain why, by also comparing repair and replacement, before discussing the challenge that...
